Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Relay Therapeutics (RLAY) Return on Assets (2020 - 2025)

Relay Therapeutics (RLAY) has disclosed Return on Assets for 6 consecutive years, with 0.43% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Assets fell 5.0% to 0.43% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.43%, a 5.0% decrease, with the full-year FY2025 number at 0.37%, up 2.0% from a year prior.
  • Return on Assets was 0.43% for Q4 2025 at Relay Therapeutics, down from 0.42% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.09% in Q1 2021 to a low of 0.43% in Q4 2021.
  • A 5-year average of 0.35% and a median of 0.38% in 2024 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: crashed -37bps in 2021, then grew 18bps in 2022.
  • Relay Therapeutics' Return on Assets stood at 0.43% in 2021, then soared by 41bps to 0.26% in 2022, then crashed by -53bps to 0.39% in 2023, then increased by 4bps to 0.37% in 2024, then decreased by -14bps to 0.43% in 2025.
  • Per Business Quant, the three most recent readings for RLAY's Return on Assets are 0.43% (Q4 2025), 0.42% (Q3 2025), and 0.41% (Q2 2025).